BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11309823)

  • 1. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study.
    Shimoyama T; Sawada K; Hiwatashi N; Sawada T; Matsueda K; Munakata A; Asakura H; Tanaka T; Kasukawa R; Kimura K; Suzuki Y; Nagamachi Y; Muto T; Nagawa H; Iizuka B; Baba S; Nasu M; Kataoka T; Kashiwagi N; Saniabadi AR
    J Clin Apher; 2001; 16(1):1-9. PubMed ID: 11309823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis.
    Yamamoto T; Umegae S; Matsumoto K
    World J Gastroenterol; 2006 Jan; 12(4):520-5. PubMed ID: 16489663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Granulocyte and monocyte adsorption apheresis in Korean conventional treatment-refractory patients with active ulcerative colitis: a prospective open-label multicenter study].
    Kim HJ; Kim JS; Han DS; Yang SK; Hahm KB; Lee WI; Kwon SW; Choi JH; Kim WH; Choi KY; Song IS
    Korean J Gastroenterol; 2005 Jan; 45(1):34-44. PubMed ID: 15665566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes.
    Saniabadi AR; Hanai H; Takeuchi K; Umemura K; Nakashima M; Adachi T; Shima C; Bjarnason I; Lofberg R
    Ther Apher Dial; 2003 Feb; 7(1):48-59. PubMed ID: 12921115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.
    Kanke K; Nakano M; Hiraishi H; Terano A
    Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis.
    Naganuma M; Funakoshi S; Sakuraba A; Takagi H; Inoue N; Ogata H; Iwao Y; Ishi H; Hibi T
    Inflamm Bowel Dis; 2004 May; 10(3):251-7. PubMed ID: 15290920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of granulocyte and monocyte adsorption apheresis for ulcerative colitis: a meta-analysis.
    Yoshino T; Nakase H; Minami N; Yamada S; Matsuura M; Yazumi S; Chiba T
    Dig Liver Dis; 2014 Mar; 46(3):219-26. PubMed ID: 24268950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study.
    Suzuki Y; Yoshimura N; Saniabadi AR; Saito Y
    Dig Dis Sci; 2004 Apr; 49(4):565-71. PubMed ID: 15185858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis.
    Yamamoto T; Saniabadi AR; Maruyama Y; Umegae S; Matsumoto K
    Dig Liver Dis; 2007 Jul; 39(7):626-33. PubMed ID: 17532273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis.
    Kashiwagi N; Sugimura K; Koiwai H; Yamamoto H; Yoshikawa T; Saniabadi AR; Adachi M; Shimoyama T
    Dig Dis Sci; 2002 Jun; 47(6):1334-41. PubMed ID: 12064810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis.
    Dignass A; Akbar A; Baumgart DC; Bommelaer G; Bouguen G; Cadiot G; Gillessen A; Grimaud JC; Hart A; Hoque S; Makins R; Michiels C; Moreau J; Premchand P; Ramlow W; Schanz S; Subramanian S; von Tirpitz C; Bonaz B
    Scand J Gastroenterol; 2018 Apr; 53(4):442-448. PubMed ID: 29513111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis Is Suitable for Elderly Patients With Active Ulcerative Colitis Taking no Corticosteroids or Biologics.
    Fukuchi T; Koga H; Kaichi S; Ishikawa A; Horita T; Araki R; Yokota A; Namba Y; Kyo M; Eguchi T; Shimazu K
    Ther Apher Dial; 2019 Jun; 23(3):224-232. PubMed ID: 31025824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.
    Sands BE; Sandborn WJ; Wolf DC; Katz S; Safdi M; Schwartz DA; Hanauer SB
    J Clin Gastroenterol; 2006 Jul; 40(6):482-9. PubMed ID: 16825929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
    Sands BE; Sandborn WJ; Feagan B; Löfberg R; Hibi T; Wang T; Gustofson LM; Wong CJ; Vandervoort MK; Hanauer S;
    Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis.
    Suzuki Y; Yoshimura N; Fukuda K; Shirai K; Saito Y; Saniabadi AR
    Dig Dis Sci; 2006 Nov; 51(11):2031-8. PubMed ID: 17004123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
    Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.
    D'Ovidio V; Aratari A; Viscido A; Marcheggiano A; Papi C; Capurso L; Caprilli R
    Dig Liver Dis; 2006 Jun; 38(6):389-94. PubMed ID: 16569521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study.
    Hanai H; Watanabe F; Takeuchi K; Iida T; Yamada M; Iwaoka Y; Saniabadi A; Matsushita I; Sato Y; Tozawa K; Arai H; Furuta T; Sugimoto K; Bjarnason I
    Clin Gastroenterol Hepatol; 2003 Jan; 1(1):28-35. PubMed ID: 15017514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adsorptive Granulocyte and Monocyte Apheresis in the Treatment of Ulcerative Colitis: The First Multicenter Study in China.
    Lai YM; Yao WY; He Y; Jiang X; Gu YB; Chen MH; Liu YL; Yuan YZ; Qian JM
    Gut Liver; 2017 Mar; 11(2):216-225. PubMed ID: 27843131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.